Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid.
暂无分享,去创建一个
Josep Vidal | Sofianos Andrikopoulos | M. Cnop | S. Kahn | R. Hull | R. Prigeon | C. Verchere | S. Andrikopoulos | J. Vidal | Steven E Kahn | Miriam Cnop | C Bruce Verchere | Feng Wang | Rebecca L Hull | Feng Wang | Ronald L Prigeon
[1] A. R. Jonckheere,et al. A DISTRIBUTION-FREE k-SAMPLE TEST AGAINST ORDERED ALTERNATIVES , 1954 .
[2] M. Löhr,et al. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. , 1985, Survey and synthesis of pathology research.
[3] Bruce A. Yankner,et al. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus , 1994, Nature.
[4] R. Turner,et al. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[5] Bernard Thorens,et al. Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet. , 2002, American journal of physiology. Endocrinology and metabolism.
[6] P. Lansbury,et al. Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes. , 2002, Biochemistry.
[7] M. Feinglos,et al. Defective Glucose‐Stimulated Insulin Release from Perifused Islets of C57BL/6J Mice , 1995, Pancreas.
[8] V. Grill,et al. Enhancing effects of long-term elevated glucose and palmitate on stored and secreted proinsulin-to-insulin ratios in human pancreatic islets. , 1999, Diabetes.
[9] J. Morris,et al. Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia , 1993, Diabetologia.
[10] K Thomaseth,et al. Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice. , 2001, American journal of physiology. Endocrinology and metabolism.
[11] W. Soeller,et al. Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[12] F. Pi‐Sunyer,et al. Medical Hazards of Obesity , 1993, Annals of Internal Medicine.
[13] J. H. Johnson,et al. Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. , 1995, The Journal of biological chemistry.
[14] J. Rodin,et al. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. , 1995, Metabolism: clinical and experimental.
[15] K. Docherty,et al. Processing of synthetic pro-islet amyloid polypeptide (proIAPP) 'amylin' by recombinant prohormone convertase enzymes, PC2 and PC3, in vitro. , 2000, European journal of biochemistry.
[16] S. Kahn,et al. Hyperproinsulinemia and Amyloid in NIDDM: Clues to Etiology of Islet β-Cell Dysfunction? , 1989, Diabetes.
[17] K. Docherty,et al. Processing of pro‐islet amyloid polypeptide (proIAPP) by the prohormone convertase PC2 , 1996, FEBS letters.
[18] P. Westermark. Amyloid and polypeptide hormones: What is their interrelationship? , 1994 .
[19] D. A. Trainor,et al. Development of sensitive immunoassays to detect amylin and amylin-like peptides in unextracted plasma. , 1996, Clinical chemistry.
[20] S. Kahn,et al. Oophorectomy promotes islet amyloid formation in a transgenic mouse model of Type II diabetes , 2000, Diabetologia.
[21] D. L. Wilson,et al. C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. , 1998, Atherosclerosis.
[22] G. Reaven. Role of Insulin Resistance in Human Disease , 1988, Diabetes.
[23] B. Lowell,et al. Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. , 2001, The Journal of clinical investigation.
[24] D. Coleman,et al. Temporal changes in pancreatic islet composition in c57bl/6j-db/db (diabetes) mice , 1983, Diabetologia.
[25] Yun-ping Zhou,et al. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. , 1994, The Journal of clinical investigation.
[26] P. Westermark,et al. Islet Amyloid Polypeptide and Insulin Secretion From Isolated Perfused Pancreas of Fed, Fasted, Glucose-Treated, and Dexamethasone-Treated Rats , 1991, Diabetes.
[27] R. Palmiter,et al. Pancreatic Expression and Secretion of Human Islet Amyloid Polypeptide in a Transgenic Mouse , 1994, Diabetes.
[28] J. McGarry,et al. Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. , 1998, The Journal of clinical investigation.
[29] C. Betsholtz,et al. Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[30] D. James,et al. Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. , 1986, The American journal of physiology.
[31] D. W. Hayden,et al. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. Miyazaki,et al. Formation of islet amyloid fibrils in beta-secretory granules of transgenic mice expressing human islet amyloid polypeptide/amylin. , 1995, European journal of endocrinology.
[33] P. Westermark,et al. Increased Release of IAPP in Response to Long-Term High Fat Intake in Mice , 1998, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[34] D. Harrison,et al. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. , 1999, Diabetes.
[35] J. Thijssen,et al. Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model , 1999, Diabetologia.
[36] S. Kahn,et al. beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes. , 2000, Diabetes.
[37] G. Pacini,et al. Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans , 2004, Diabetologia.
[38] B. Ahrén. Reducing plasma free fatty acids by acipimox improves glucose tolerance in high-fat fed mice. , 2001, Acta physiologica Scandinavica.
[39] M. Carty,et al. Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide. , 1998, Diabetes.
[40] C. Howard. Longitudinal studies on the development of diabetes in individual Macaca nigra , 1986, Diabetologia.
[41] G. Cooper,et al. Induction of apoptosis by human amylin in RINm5F islet β‐cells is associated with enhanced expression of p53 and p21WAF1/CIP1 , 1999, FEBS letters.
[42] J. Finnerty,et al. The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site. , 2001, Diabetes.
[43] S. Kahn,et al. Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes. , 1999, Diabetes.
[44] M. Cnop,et al. Islet amyloid develops diffusely throughout the pancreas before becoming severe and replacing endocrine cells. , 2001, Diabetes.
[45] P. Westermark,et al. Quantitative studies on amyloid in the islets of Langerhans. , 1972, Upsala journal of medical sciences.
[46] F. Sundler,et al. Differential changes in islet amyloid polypeptide (amylin) and insulin mRNA expression after high-fat diet-induced insulin resistance in C57BL/6J mice. , 2000, Metabolism: clinical and experimental.
[47] D. Steiner,et al. Human islet amyloid polypeptide transgenic mice as a model of non‐insulin‐dependent diabetes mellitus (NIDDM) , 1993, FEBS letters.
[48] R. Holman,et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. , 1988, Diabetes research.
[49] R. Surwit,et al. Differential effects of fat and sucrose on body composition in A/J and C57BL/6 mice. , 1998, Metabolism: clinical and experimental.
[50] S. Kahn,et al. The Importance of β-Cell Failure in the Development and Progression of Type 2 Diabetes , 2001 .
[51] S. Bloom,et al. Altered islet amyloid polypeptide (amylin) gene expression in rat models of diabetes , 1989, Diabetologia.
[52] D. Steiner,et al. Long-term elevation of free fatty acids leads to delayed processing of proinsulin and prohormone convertases 2 and 3 in the pancreatic beta-cell line MIN6. , 1999, Diabetes.
[53] P. Bennett,et al. Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians , 1990, Diabetologia.
[54] R. Palmiter,et al. Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[55] F Vinicor,et al. The continuing epidemics of obesity and diabetes in the United States. , 2001, JAMA.
[56] G. Cooper,et al. Amylin secretion from the perfused pancreas: dissociation from insulin and abnormal elevation in insulin-resistant diabetic rats. , 1991, Biochemical and biophysical research communications.
[57] A. Lazarow,et al. Immunoassay of Insulin: Two Antibody System: Plasma Insulin Levels of Normal, Subdiabetic and Diabetic Rats , 1963, Diabetes.
[58] R. Hamman,et al. Dietary Fat Predicts Conversion From Impaired Glucose Tolerance to NIDDM: The San Luis Valley Diabetes Study , 1994, Diabetes Care.